Cargando…
γδ T Cell Immunotherapy—A Review
Cancer immunotherapy utilizing Vγ9Vδ2 T cells has been developed over the past decade. A large number of clinical trials have been conducted on various types of solid tumors as well as hematological malignancies. Vγ9Vδ2 T cell-based immunotherapy can be classified into two categories based on the me...
Autores principales: | Kobayashi, Hirohito, Tanaka, Yoshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381201/ https://www.ncbi.nlm.nih.gov/pubmed/25686210 http://dx.doi.org/10.3390/ph8010040 |
Ejemplares similares
-
γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014) -
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
por: Tanaka, Yoshimasa, et al.
Publicado: (2018) -
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015) -
γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016) -
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)